| External factors: | Disulfiram and doxorubicin |
| Aging type: | Accelerate |
| Aging characteristic: |
| Category: | Chemical compounds |
| Phenotype: | Breast cancer |
| Experiment: | SA-β-gal activity assay |
| Description: | We found that doxorubicin or DSF treatment cultures showed X-gal-positive cells (29.9% and 23.0%, respectively), and that doxorubicin plus DSF treatment resulted in an additive effect (42.4%). |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: